Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
IO lays off 50% after FDA derails cancer vaccine approval plan
IO Biotech has resorted to halving its workforce after the FDA knocked back its plans to seek approval for its cancer vaccine.
James Waldron
Sep 29, 2025 8:55am
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
Trump admin mulls 'severe restrictions' on new China drugs: NYT
Sep 10, 2025 9:16am
Capricor responds to cell therapy snub, disputes FDA’s concerns
Sep 9, 2025 11:44am
'Several concerning observations': FDA sheds light on rejections
Sep 5, 2025 10:45am
FDA plans real-time release of drug rejection letters
Sep 4, 2025 1:45pm